Opportunities
Entrepreneurs and venture-backed companies seeking financing in the near term, take notice. The hot market for companies is going to cool off in 3 to 6 months. Hurry up and get your round closed before it gets harder and terms get tougher. In my 20 years of participating in the venture market both as a […]
Read MoreJuly 1, 2011 source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]
Read More
April 21, 2011 source: Gigaom When it comes to clean-energy investing 2.0, venture capitalists are beyond looking for the silver bullet — or the magic battery –- they spent the last decade hunting and hoping for. Today, VCs are more likely to invest their dollars in slightly less ambitious energy-efficiency projects, Paul Kedrosky, senior fellow […]
Read MoreFebruary 16, 2011 source: peHUB Remember the Internet’s last mile dilemma? The smart grid may have its own a last mile difficulties. High costs and immature technologies could leave consumers short of power and utilities with few options to deliver it. Both dilemmas will restrict the nation’s ability to manage power in an age of […]
Read MoreWhen I was in high school back in the 70’s, I remember my favorite physics teacher telling me about the difference between data and information. Data was raw, unprocessed and unlinked to any meaning. Information was what data became when it was linked to meaning. This was an important distinction that has even greater meaning […]
Read MoreI was at an event with a group of MBA students a couple of weeks ago, chatting with two of them. One asked me how the venture deal flow was different in the past. I made the off-hand comment that the World of Could seemed to have grown much bigger, but the World of Should […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.